Global and Japan Pharmacokinetics Services Market 2020 by Company, Type and Application, Forecast to 2025

Table of Contents

1 Pharmacokinetics Services Market Overview

• 1.1 Product Overview and Scope of Pharmacokinetics Services
• 1.2 Classification of Pharmacokinetics Services by Type
  • 1.2.1 Global Pharmacokinetics Services Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Pharmacokinetics Services Revenue Market Share by Type in 2019
  • 1.2.3 Small Molecules Pharmacokinetics Services
  • 1.2.4 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
• 1.3 Global Pharmacokinetics Services Market by Application
  • 1.3.1 Overview: Global Pharmacokinetics Services Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Small & Medium Enterprise
  • 1.3.3 Large Enterprise
• 1.4 Global Pharmacokinetics Services Market by Regions
  • 1.4.1 Global Pharmacokinetics Services Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Pharmacokinetics Services (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Pharmacokinetics Services Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Pharmacokinetics Services Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmacokinetics Services Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Pharmacokinetics Services Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmacokinetics Services Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Evotec AG (Germany)
  • 2.1.1 Evotec AG (Germany) Details
  • 2.1.2 Evotec AG (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Evotec AG (Germany) SWOT Analysis
  • 2.1.4 Evotec AG (Germany) Product and Services
  • 2.1.5 Evotec AG (Germany) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Eurofins Scientific, Inc. (Luxembourg)
  • 2.2.1 Eurofins Scientific, Inc. (Luxembourg) Details
  • 2.2.2 Eurofins Scientific, Inc. (Luxembourg) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Eurofins Scientific, Inc. (Luxembourg) SWOT Analysis
  • 2.2.4 Eurofins Scientific, Inc. (Luxembourg) Product and Services
  • 2.2.5 Eurofins Scientific, Inc. (Luxembourg) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Shanghai Medicilon Inc. (China)
  • 2.3.1 Shanghai Medicilon Inc. (China) Details
  • 2.3.2 Shanghai Medicilon Inc. (China) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Shanghai Medicilon Inc. (China) SWOT Analysis
  • 2.3.4 Shanghai Medicilon Inc. (China) Product and Services
  • 2.3.5 Shanghai Medicilon Inc. (China) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Pacific BioLabs (US)
  • 2.4.1 Pacific BioLabs (US) Details
  • 2.4.2 Pacific BioLabs (US) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Pacific BioLabs (US) SWOT Analysis
  • 2.4.4 Pacific BioLabs (US) Product and Services
  • 2.4.5 Pacific BioLabs (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 PAREXEL International Corporation (US)
  • 2.5.1 PAREXEL International Corporation (US) Details
  • 2.5.2 PAREXEL International Corporation (US) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 PAREXEL International Corporation (US) SWOT Analysis
  • 2.5.4 PAREXEL International Corporation (US) Product and Services
  • 2.5.5 PAREXEL International Corporation (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 GVK Biosciences Private Limited (India)
  • 2.6.1 GVK Biosciences Private Limited (India) Details
  • 2.6.2 GVK Biosciences Private Limited (India) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 GVK Biosciences Private Limited (India) SWOT Analysis
  • 2.6.4 GVK Biosciences Private Limited (India) Product and Services
  • 2.6.5 GVK Biosciences Private Limited (India) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 SGS SA (Switzerland)
  • 2.7.1 SGS SA (Switzerland) Details
  • 2.7.2 SGS SA (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 SGS SA (Switzerland) SWOT Analysis
  • 2.7.4 SGS SA (Switzerland) Product and Services
  • 2.7.5 SGS SA (Switzerland) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Charles River Laboratories International, Inc. (US)
  • 2.8.1 Charles River Laboratories International, Inc. (US) Details
  • 2.8.2 Charles River Laboratories International, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Charles River Laboratories International, Inc. (US) SWOT Analysis
  • 2.8.4 Charles River Laboratories International, Inc. (US) Product and Services
  • 2.8.5 Charles River Laboratories International, Inc. (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Pharmaceutical Product Development, LLC (US)
  • 2.9.1 Pharmaceutical Product Development, LLC (US) Details
  • 2.9.2 Pharmaceutical Product Development, LLC (US) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Pharmaceutical Product Development, LLC (US) SWOT Analysis
  • 2.9.4 Pharmaceutical Product Development, LLC (US) Product and Services
  • 2.9.5 Pharmaceutical Product Development, LLC (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Frontage Labs (US)
  • 2.10.1 Frontage Labs (US) Details
  • 2.10.2 Frontage Labs (US) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Frontage Labs (US) SWOT Analysis
  • 2.10.4 Frontage Labs (US) Product and Services
  • 2.10.5 Frontage Labs (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 LGC Limited (UK)
  • 2.11.1 LGC Limited (UK) Details
  • 2.11.2 LGC Limited (UK) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 LGC Limited (UK) SWOT Analysis
  • 2.11.4 LGC Limited (UK) Product and Services
  • 2.11.5 LGC Limited (UK) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 Creative Bioarray (US)
  • 2.12.1 Creative Bioarray (US) Details
  • 2.12.2 Creative Bioarray (US) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 Creative Bioarray (US) SWOT Analysis
  • 2.12.4 Creative Bioarray (US) Product and Services
  • 2.12.5 Creative Bioarray (US) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 Certara, L.P. (Germany)
  • 2.13.1 Certara, L.P. (Germany) Details
  • 2.13.2 Certara, L.P. (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 Certara, L.P. (Germany) SWOT Analysis
  • 2.13.4 Certara, L.P. (Germany) Product and Services
  • 2.13.5 Certara, L.P. (Germany) Pharmacokinetics Services Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Pharmacokinetics Services Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Pharmacokinetics Services Players Market Share
  • 3.2.2 Top 10 Pharmacokinetics Services Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Pharmacokinetics Services Revenue and Market Share by Regions
• 4.2 North America Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 4.3 Europe Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 4.5 South America Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Pharmacokinetics Services Revenue and Growth Rate (2015-2020)

5 North America Pharmacokinetics Services Revenue by Countries

• 5.1 North America Pharmacokinetics Services Revenue by Countries (2015-2020)
• 5.2 USA Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 5.3 Canada Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Pharmacokinetics Services Revenue and Growth Rate (2015-2020)

6 Europe Pharmacokinetics Services Revenue by Countries

• 6.1 Europe Pharmacokinetics Services Revenue by Countries (2015-2020)
• 6.2 Germany Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 6.3 UK Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 6.4 France Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 6.5 Russia Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 6.6 Italy Pharmacokinetics Services Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Pharmacokinetics Services Revenue by Countries

• 7.1 Asia-Pacific Pharmacokinetics Services Revenue by Countries (2015-2020)
• 7.2 China Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 7.3 Japan Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 7.4 Korea Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 7.5 India Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Pharmacokinetics Services Revenue and Growth Rate (2015-2020)

8 South America Pharmacokinetics Services Revenue by Countries

• 8.1 South America Pharmacokinetics Services Revenue by Countries (2015-2020)
• 8.2 Brazil Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Pharmacokinetics Services Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Pharmacokinetics Services by Countries

• 9.1 Middle East & Africa Pharmacokinetics Services Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 9.3 UAE Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Pharmacokinetics Services Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Pharmacokinetics Services Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Pharmacokinetics Services Revenue and Market Share by Type (2015-2020)
• 10.2 Global Pharmacokinetics Services Market Forecast by Type (2019-2024)
• 10.3 Small Molecules Pharmacokinetics Services Revenue Growth Rate (2015-2025)
• 10.4 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services Revenue Growth Rate (2015-2025)

11 Global Pharmacokinetics Services Market Segment by Application

• 11.1 Global Pharmacokinetics Services Revenue Market Share by Application (2015-2020)
• 11.2 Pharmacokinetics Services Market Forecast by Application (2019-2024)
• 11.3 Small & Medium Enterprise Revenue Growth (2015-2020)
• 11.4 Large Enterprise Revenue Growth (2015-2020)

12 Global Pharmacokinetics Services Market Size Forecast (2021-2025)

• 12.1 Global Pharmacokinetics Services Market Size Forecast (2021-2025)
• 12.2 Global Pharmacokinetics Services Market Forecast by Regions (2021-2025)
• 12.3 North America Pharmacokinetics Services Revenue Market Forecast (2021-2025)
• 12.4 Europe Pharmacokinetics Services Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Pharmacokinetics Services Revenue Market Forecast (2021-2025)
• 12.6 South America Pharmacokinetics Services Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Pharmacokinetics Services Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer